Fred Alger Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $208K | Sell |
3,690
-1,865
| -34% | -$109K | ﹤0.01% | 433 |
|
|
2025
Q4 | $330K | Sell |
5,555
-18,145
| -77% | -$988K | ﹤0.01% | 414 |
|
|
2025
Q3 | $1.28M | Sell |
23,700
-4,907
| -17% | -$281K | 0.01% | 345 |
|
|
2025
Q2 | $1.57M | Sell |
28,607
-196
| -0.7% | -$11.5K | 0.01% | 329 |
|
|
2025
Q1 | $2.04M | Buy |
28,803
+2,933
| +11% | +$197K | 0.01% | 299 |
|
|
2024
Q4 | $1.7M | Sell |
25,870
-703
| -3% | -$47.1K | 0.01% | 342 |
|
|
2024
Q3 | $1.87M | Sell |
26,573
-2,943
| -10% | -$246K | 0.01% | 330 |
|
|
2024
Q2 | $2.43M | Sell |
29,516
-1,664
| -5% | -$139K | 0.01% | 310 |
|
|
2024
Q1 | $2.72M | Sell |
31,180
-2,209
| -7% | -$198K | 0.01% | 318 |
|
|
2023
Q4 | $3.22M | Sell |
33,389
-7,493
| -18% | -$663K | 0.02% | 289 |
|
|
2023
Q3 | $3.62M | Sell |
40,882
-6,715
| -14% | -$597K | 0.02% | 274 |
|
|
2023
Q2 | $4.13M | Sell |
47,597
-85,326
| -64% | -$8.03M | 0.02% | 267 |
|
|
2023
Q1 | $12.9M | Buy |
132,923
+60,297
| +83% | +$6.25M | 0.07% | 180 |
|
|
2022
Q4 | $7.52M | Buy |
72,626
+33,940
| +88% | +$3.19M | 0.04% | 231 |
|
|
2022
Q3 | $3.28M | Sell |
38,686
-32,718
| -46% | -$2.91M | 0.02% | 289 |
|
|
2022
Q2 | $5.92M | Sell |
71,404
-51,391
| -42% | -$4.09M | 0.03% | 247 |
|
|
2022
Q1 | $9.47M | Sell |
122,795
-93,055
| -43% | -$7.79M | 0.03% | 225 |
|
|
2021
Q4 | $19.1M | Buy |
215,850
+174,998
| +428% | +$14.4M | 0.05% | 211 |
|
|
2021
Q3 | $3.16M | Buy |
40,852
+2,701
| +7% | +$213K | 0.01% | 321 |
|
|
2021
Q2 | $3.18M | Buy |
38,151
+7,711
| +25% | +$611K | 0.01% | 329 |
|
|
2021
Q1 | $2.3M | Sell |
30,440
-415,970
| -93% | -$34M | 0.01% | 338 |
|
|
2020
Q4 | $39.1M | Buy |
446,410
+66,567
| +18% | +$5.28M | 0.1% | 160 |
|
|
2020
Q3 | $28.9M | Sell |
379,843
-853,768
| -69% | -$86.4M | 0.08% | 151 |
|
|
2020
Q2 | $152M | Buy |
1,233,611
+1,215,604
| +6,751% | +$121M | 0.5% | 50 |
|
|
2020
Q1 | $1.52M | Buy |
18,007
+6,937
| +63% | +$598K | 0.01% | 293 |
|
|
2019
Q4 | $936K | Buy |
11,070
+4,314
| +64% | +$326K | ﹤0.01% | 349 |
|
|
2019
Q3 | $455K | Sell |
6,756
-13,247
| -66% | -$1.02M | ﹤0.01% | 374 |
|
|
2019
Q2 | $1.71M | Buy |
20,003
+3,553
| +22% | +$304K | 0.01% | 299 |
|
|
2019
Q1 | $1.46M | Sell |
16,450
-672,286
| -98% | -$62.3M | 0.01% | 302 |
|
|
2018
Q4 | $58.6M | Sell |
688,736
-164,677
| -19% | -$15.7M | 0.27% | 83 |
|
|
2018
Q3 | $82.8M | Sell |
853,413
-121,060
| -12% | -$12.1M | 0.31% | 79 |
|
|
2018
Q2 | $91.8M | Buy |
974,473
+39,852
| +4% | +$3.49M | 0.39% | 53 |
|
|
2018
Q1 | $75.8M | Sell |
934,621
-89,411
| -9% | -$7.67M | 0.35% | 63 |
|
|
2017
Q4 | $91.3M | Buy |
1,024,032
+3,793
| +0.4% | +$330K | 0.41% | 63 |
|
|
2017
Q3 | $95M | Sell |
1,020,239
-8,790
| -0.9% | -$777K | 0.44% | 56 |
|
|
2017
Q2 | $93.5M | Sell |
1,029,029
-84,226
| -8% | -$7.66M | 0.45% | 59 |
|
|
2017
Q1 | $97.7M | Buy |
1,113,255
+28,122
| +3% | +$2.5M | 0.49% | 52 |
|
|
2016
Q4 | $89.9M | Sell |
1,085,133
-559,696
| -34% | -$48.1M | 0.49% | 53 |
|
|
2016
Q3 | $152M | Buy |
1,644,829
+209,042
| +15% | +$19.7M | 0.78% | 30 |
|
|
2016
Q2 | $112M | Buy |
1,435,787
+196,503
| +16% | +$16.7M | 0.59% | 44 |
|
|
2016
Q1 | $102M | Buy |
1,239,284
+860,439
| +227% | +$70M | 0.52% | 53 |
|
|
2015
Q4 | $39.7M | Sell |
378,845
-260,586
| -41% | -$27.2M | 0.19% | 92 |
|
|
2015
Q3 | $67.3M | Sell |
639,431
-219,973
| -26% | -$29.4M | 0.37% | 71 |
|
|
2015
Q2 | $118M | Buy |
859,404
+289,873
| +51% | +$35.9M | 0.53% | 56 |
|
|
2015
Q1 | $71M | Buy |
569,531
+493,871
| +653% | +$52.3M | 0.32% | 87 |
|
|
2014
Q4 | $6.84M | Buy |
75,660
+7,125
| +10% | +$593K | 0.03% | 306 |
|
|
2014
Q3 | $4.95M | Sell |
68,535
-36,274
| -35% | -$2.38M | 0.02% | 342 |
|
|
2014
Q2 | $6.52M | Sell |
104,809
-109,175
| -51% | -$6.6M | 0.03% | 334 |
|
|
2014
Q1 | $14.6M | Sell |
213,984
-56,075
| -21% | -$4.13M | 0.07% | 258 |
|
|
2013
Q4 | $19M | Buy |
270,059
+161,642
| +149% | +$11M | 0.1% | 223 |
|
|
2013
Q3 | $7.82M | Buy |
108,417
+73,179
| +208% | +$4.86M | 0.04% | 308 |
|
|
2013
Q2 | $1.96M | Buy |
+35,238
| New | +$2.2M | 0.01% | 390 |
|
Other funds holding BMRN
VCM
VPM
Fred Alger Management's BMRN Position: Q1 2026 in Review
Fred Alger Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 34% in Q1 2026, selling an estimated $109K and leaving 3,690 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #433.
Fred Alger Management first reported a position in BMRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $152M in Q3 2016. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Fred Alger Management held 3,690 shares of BioMarin Pharmaceuticals worth $208K as of Q1 2026.
- Fred Alger Management sold 1,865 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $109K.
- BioMarin Pharmaceuticals made up ﹤0.01% of Fred Alger Management's portfolio in Q1 2026, its #433 holding.
- Fred Alger Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Fred Alger Management's BioMarin Pharmaceuticals position peaked at $152M in Q3 2016.
- 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.